Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults.
Saved in:
| Title: | Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults. |
|---|---|
| Authors: | Healy SA; Center for Infectious Disease Research, Seattle, Washington, USA.; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington, Seattle, Washington, USA.; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Murphy SC; Center for Infectious Disease Research, Seattle, Washington, USA.; Department of Laboratory Medicine and Microbiology, University of Washington, Seattle, Washington, USA.; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA., Hume JCC; Center for Infectious Disease Research, Seattle, Washington, USA.; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Shelton L; Center for Infectious Disease Research, Seattle, Washington, USA., Kuntz S; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA., Van Voorhis WC; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, Washington, USA.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA., Moodie Z; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Metch B; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Wang R; Center for Infectious Disease Research, Seattle, Washington, USA., Silver-Brace T; Center for Infectious Disease Research, Seattle, Washington, USA., Fishbaugher M; Center for Infectious Disease Research, Seattle, Washington, USA., Kennedy M; Center for Infectious Disease Research, Seattle, Washington, USA., Finney OC; Center for Infectious Disease Research, Seattle, Washington, USA., Chaturvedi R; Center for Infectious Disease Research, Seattle, Washington, USA., Marcsisin SR; Military Malaria Research Program, Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA., Hobbs CV; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Warner-Lubin M; Center for Infectious Disease Research, Seattle, Washington, USA.; C3 Research Associates, Seattle, Washington, USA., Talley AK; Center for Infectious Disease Research, Seattle, Washington, USA., Wong-Madden S; Center for Infectious Disease Research, Seattle, Washington, USA.; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Stuart K; Center for Infectious Disease Research, Seattle, Washington, USA., Wald A; Department of Laboratory Medicine and Microbiology, University of Washington, Seattle, Washington, USA.; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Epidemiology, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA., Kappe SH; Center for Infectious Disease Research, Seattle, Washington, USA., Kublin JG; Center for Infectious Disease Research, Seattle, Washington, USA.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Duffy PE; Center for Infectious Disease Research, Seattle, Washington, USA.; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Sep 12; Vol. 71 (6), pp. 1481-1490. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
